SEER Data Show Under Age 55 Death Rates are Decreasing, Mixed Results In Various Categories
In Brief: Fischinger Hints of “New Player” At FCRF; Gigliotti Named Cancer Control Science Director
About Face; NCI To Keep Preclinical AIDS Drug Development
EORTC Places Same Number on Phase 2-3 Trials As In U.S.
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Tumors are able to form with no DNA mutations, fly study shows
- From clinician scientist to nonprofit CEO